Advertisement

Geographic Variability in Human Papillomavirus Vaccination Among U.S. Young Women

      Background

      Little information is available on geographic disparity of human papillomavirus (HPV) vaccination among women aged 18–26 years in the U.S. Genital HPV is the most common sexually transmitted infection in the U.S. Persistent HPV infection with oncogenic types can cause cervical cancer.

      Purpose

      This study utilized data collected from the 2010 National Health Interview Survey (NHIS). It identified geographic variability and other factors contributing to the disparities in HPV vaccine series initiation in a nationally representative sample of women aged 18–26 years.

      Methods

      The study utilized data collected from 1867 women who participated in the Cancer Control Module Supplement of the 2012 NHIS. A multivariable logistic regression model was used to assess characteristics associated with initiation of the HPV series. Analyses were performed in 2012.

      Results

      After adjusting for other characteristics, women living in the West and North Central/Midwest had 54% and 20% greater odds of initiating the HPV series, respectively, compared with those living in the Northeast. Other factors associated with HPV series initiation were younger age, Hispanic background, being single/never married, childlessness, a history of HPV, and current alcohol use. Factors correlated with failure to initiate the HPV series were: not having insurance, living below the 200% poverty level, not being a high school graduate, not currently using hormone-based birth control, most recent Pap >1 year ago, no regular provider, last clinic visit ≥12 months ago, and never having received the hepatitis B vaccine.

      Conclusions

      Results demonstrate disparity in HPV vaccine uptake by region of residence in the U.S. among young women. Further research is needed to understand the factors contributing to this geographic disparity. Evaluation of vaccination policies and practices associated with higher coverage regions might help characterize effective methods to improve HPV vaccination among women aged 18–26 years.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Preventive Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Weinstock H.
        • Berman S.
        • Cates Jr, W.
        Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000.
        Perspect Sexual Reprod Health. 2004; 36: 6-10
        • Markowitz L.E.
        • Dunne E.F.
        • Saraiya M.
        • et al.
        Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
        MMWR Recomm Rep. 2007; 56: 1-24
        • CDC
        National and state vaccination coverage among adolescents aged 13 through 17 years—U.S., 2010.
        MMWR Morb Mortal Wkly Rep. 2011; 60: 1117-1123
        • CDC
        Adult vaccination coverage—U.S., 2010.
        MMWR Morb Mortal Wkly Rep. 2012; 61: 66-72
        • Bednarczyk R.A.
        • Birkhead G.S.
        • Morse D.L.
        • Doleyres H.
        • McNutt L.A.
        Human papillomavirus vaccine uptake and barriers: association with perceived risk, actual risk and race/ethnicity among female students at a New York state university, 2010.
        Vaccine. 2011; 29: 3138-3143
        • Chao C.
        • Velicer C.
        • Slezak J.M.
        • Jacobsen S.J.
        Correlates for human papillomavirus vaccination of adolescent girls and young women in a managed care organization.
        Am J Epidemiol. 2010; 171: 357-367
        • Dempsey A.
        • Cohn L.
        • Dalton V.
        • Ruffin M.
        Worsening disparities in HPV vaccine utilization among 19-26 year old women.
        Vaccine. 2011; 29: 528-534
        • Ford J.L.
        Racial and ethnic disparities in human papillomavirus awareness and vaccination among young adult women.
        Public Health Nurs. 2011; 28: 485-493
        • Jain N.
        • Euler G.L.
        • Shefer A.
        • Lu P.
        • Yankey D.
        • Markowitz L.
        Human papillomavirus (HPV) awareness and vaccination initiation among women in the U.S., National Immunization Survey–Adult.
        Prev Med. 2009; 48: 426-431
        • Liddon N.C.
        • Leichliter J.S.
        • Markowitz L.E.
        Human papillomavirus vaccine and sexual behavior among adolescent and young women.
        Am J Prev Med. 2012; 42: 44-52
        • Mills L.A.
        • Vanderpool R.C.
        • Crosby R.A.
        Sexually related behaviors as predictors of HPV vaccination among young rural women.
        J Women's Health. 2011; 20: 1909-1915
        • CDC
        2010 National Health Interview Survey (NHIS) public use data release.
        DHHS, CDC, Atlanta GA2011
        ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/Survey_Questionnaires/NHIS/2010/English/qcancer.pdf
        • CDC
        Variance Estimation and Other Analytic Issues, NHIS 2006-2010.
        DHHS, CDC, Atlanta GA2011
        • Pruitt S.L.
        • Schootman M.
        Geographic disparity, area poverty, and human papillomavirus vaccination.
        Am J Prev Med. 2010; 38: 525-533
        • Kadis J.A.
        • McRee A.-L.
        • Gottlieb S.L.
        • et al.
        Mothers' support for voluntary provision of HPV vaccine in schools.
        Vaccine. 2011; 29: 2542-2547
        • Vadaparampil S.T.
        • Kahn J.A.
        • Salmon D.
        • et al.
        Missed clinical opportunities: provider recommendations for HPV vaccination for 11–12 year old girls are limited.
        Vaccine. 2011; 29: 8634-8641
        • Blumberg S.J.
        • Luke J.V.
        • Cynamon M.L.
        Telephone coverage and health survey estimates: evaluating the need for concern about wireless substitution.
        Am J Public Health. 2006; : 926-931